Advertisement
Advertisement
U.S. markets open in 2 hours 50 minutes
S&P Futures
3,810.00 -17.25 (-0.45%) Dow Futures
30,933.00 -128.00 (-0.41%) Nasdaq Futures
11,547.00 -64.25 (-0.55%) Russell 2000 Futures
1,717.40 -11.10 (-0.64%) Crude Oil
108.43 0.00 (0.00%) Gold
1,803.50 +2.00 (+0.11%)
IVERIC bio, Inc. (ISEE)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
Advertisement
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Performance Outlook
| Previous Close | 9.62 |
| Open | 9.64 |
| Bid | 0.00 x 2200 |
| Ask | 0.00 x 3200 |
| Day's Range | 9.15 - 9.84 |
| 52 Week Range | 7.55 - 19.34 |
| Volume | |
| Avg. Volume | 1,987,345 |
| Market Cap | 1.094B |
| Beta (5Y Monthly) | 1.55 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -1.13 |
| Earnings Date | Aug 02, 2022 - Aug 08, 2022 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 24.00 |
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued
Subscribe to Yahoo Finance Plus to view Fair Value for ISEE
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
- IVERIC bio, Inc.Technical Assessment: Bearish in the Intermediate-TermMonday provided a much-needed rest for the stock market after a very large rebound last week. Following that strong week (and we've seen this before during the current decline), the "bottom-callers" are out, but not in big numbers. That's probably a good thing, as others are calling this another bear-market rally. From a technical perspective and using our own interpretation, it is far too early to call the bottom as there is just not enough of the needed evidence.RatingFair ValueEconomic Moat7 days agoArgus Research
- Business Wire
Iveric Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
PARSIPPANY, N.J., July 01, 2022--Iveric Bio granted equity-based awards pursuant to the Company’s 2019 Inducement Stock Incentive Plan to one newly-hired, non-executive employee.
- Business Wire
Iveric Bio Announces Presentation of Post-Hoc Analysis at Macula Society from GATHER1 Clinical Trial of Zimura® in Patients with Geographic Atrophy
PARSIPPANY, N.J., June 10, 2022--Iveric Bio announced its presentation of a post-hoc analysis from the Zimura GATHER1 clinical trial at the Macula Society Meeting in Berlin, Germany.
- Simply Wall St.
IVERIC bio, Inc. (NASDAQ:ISEE) insiders are still down US$16k after purchasing last year, recent gain helped regain some losses
Insiders who bought US$50k worth of IVERIC bio, Inc. ( NASDAQ:ISEE ) stock in the last year recovered part of their...
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
© 2022 Yahoo. All rights reserved.
